CUREVAC NVLong
Trading Idea - #CUREVAC (hope for the mutants)
THE BIG LONG! Vaccine for the Covid-Mutants! :-)
ENTRY: 44.20 EUR
TARGET: 90.00 EUR (104 % profit)
STOP: 32.40 EUR
- This is only an interim analysis result of the CUREVAC Covid vaccince!!
- Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues.
- The vaccine candidate is in the final stage of clinical development.
- CEO Franz-Werner Haas announced that one had hoped for stronger results in the interim analysis.
- But continue the current study until the final analysis.
ENTRY: 44.20 EUR
TARGET: 90.00 EUR (104 % profit)
STOP: 32.40 EUR
- This is only an interim analysis result of the CUREVAC Covid vaccince!!
- Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues.
- The vaccine candidate is in the final stage of clinical development.
- CEO Franz-Werner Haas announced that one had hoped for stronger results in the interim analysis.
- But continue the current study until the final analysis.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.